Ceribell Stock Market Outlook
| CBLL Stock | 20.57 0.22 1.06% |
About 56% of CeriBell's investor base is looking to short. The analysis of overall sentiment of trading CeriBell stock suggests that many investors are alarmed at this time. CeriBell's investing sentiment shows overall attitude of investors towards CeriBell.
Comfort Level 44
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use CeriBell's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward CeriBell.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding CeriBell is 'Strong Hold'. The recommendation algorithm takes into account all of CeriBell's available fundamental, technical, and predictive indicators you will find on this site.
Execute CeriBell Advice
The CeriBell recommendation should be used to complement the investment advice compiled from the current analysts' consensus on CeriBell. Macroaxis does not own or have any residual interests in CeriBell or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute CeriBell's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Solid | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
For the selected time horizon CeriBell has a Risk Adjusted Performance of 0.2395, Jensen Alpha of 0.9266, Total Risk Alpha of 0.6349, Sortino Ratio of 0.3503 and Treynor Ratio of (7.34)Our investment recommendation module complements current analysts and expert consensus on CeriBell. It analyzes the firm potential to grow using all fundamental, technical, and market related data available at the time. To make sure CeriBell is not overpriced, please confirm all CeriBell fundamentals, including its price to sales, short ratio, net asset, as well as the relationship between the net income and market capitalization . Given that CeriBell has a shares owned by insiders of 10.31 %, we suggest you to validate CeriBell market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.
CeriBell Trading Alerts and Improvement Suggestions
| CeriBell appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 65.44 M. Net Loss for the year was (40.45 M) with profit before overhead, payroll, taxes, and interest of 72.87 M. | |
| CeriBell generates negative cash flow from operations | |
| CeriBell has a poor financial position based on the latest SEC disclosures | |
| Over 85.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from globenewswire.com: Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 |
CeriBell Returns Distribution Density
The distribution of CeriBell's historical returns is an attempt to chart the uncertainty of CeriBell's future price movements. The chart of the probability distribution of CeriBell daily returns describes the distribution of returns around its average expected value. We use CeriBell price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of CeriBell returns is essential to provide solid investment analysis for CeriBell.
| Mean Return | 0.93 | Value At Risk | -3.94 | Potential Upside | 6.39 | Standard Deviation | 3.25 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of CeriBell historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
CeriBell Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to CeriBell or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that CeriBell's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a CeriBell stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.93 | |
β | Beta against Dow Jones | -0.12 | |
σ | Overall volatility | 3.24 | |
Ir | Information ratio | 0.26 |
CeriBell Volatility Alert
CeriBell currently demonstrates below-average downside deviation. It has Information Ratio of 0.26 and Jensen Alpha of 0.93. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure CeriBell's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact CeriBell's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.CeriBell Fundamentals Vs Peers
Comparing CeriBell's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze CeriBell's direct or indirect competition across all of the common fundamentals between CeriBell and the related equities. This way, we can detect undervalued stocks with similar characteristics as CeriBell or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of CeriBell's fundamental indicators could also be used in its relative valuation, which is a method of valuing CeriBell by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare CeriBell to competition |
| Fundamentals | CeriBell | Peer Average |
| Return On Equity | -0.6 | -0.31 |
| Return On Asset | -0.29 | -0.14 |
| Profit Margin | (0.63) % | (1.27) % |
| Operating Margin | (0.65) % | (5.51) % |
| Current Valuation | 615.86 M | 16.62 B |
| Shares Outstanding | 37.1 M | 571.82 M |
| Shares Owned By Insiders | 10.31 % | 10.09 % |
| Shares Owned By Institutions | 84.91 % | 39.21 % |
| Number Of Shares Shorted | 1.63 M | 4.71 M |
| Price To Book | 4.65 X | 9.51 X |
| Price To Sales | 9.21 X | 11.42 X |
| Revenue | 65.44 M | 9.43 B |
| Gross Profit | 72.87 M | 27.38 B |
| EBITDA | (37.32 M) | 3.9 B |
| Net Income | (40.45 M) | 570.98 M |
| Total Debt | 21.96 M | 5.32 B |
| Book Value Per Share | 4.43 X | 1.93 K |
| Cash Flow From Operations | (35.04 M) | 971.22 M |
| Short Ratio | 3.98 X | 4.00 X |
| Earnings Per Share | (3.67) X | 3.12 X |
| Target Price | 28.14 | |
| Number Of Employees | 281 | 18.84 K |
| Market Capitalization | 763.06 M | 19.03 B |
| Total Asset | 225.41 M | 29.47 B |
| Retained Earnings | (166.94 M) | 9.33 B |
| Working Capital | 204.28 M | 1.48 B |
| Net Asset | 225.41 M |
Note: Disposition of 23554 shares by Xingjuan Chao of CeriBell at 4.7 subject to Rule 16b-3 [view details]
CeriBell Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as CeriBell . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
CeriBell Target Price Consensus
CeriBell target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. CeriBell's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 5 | Strong Buy |
Most CeriBell analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand CeriBell stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of CeriBell, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationCeriBell Target Price Projection
CeriBell's current and average target prices are 20.57 and 28.14, respectively. The current price of CeriBell is the price at which CeriBell is currently trading. On the other hand, CeriBell's target price is what analysts think the stock is worth. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
CeriBell Market Quote on 13th of February 2026
Target Price
Analyst Consensus On CeriBell Target Price
CeriBell Analyst Ratings
CeriBell's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about CeriBell stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of CeriBell's financials, market performance, and future outlook by experienced professionals. CeriBell's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
About CeriBell Buy or Sell Advice
When is the right time to buy or sell CeriBell? Buying financial instruments such as CeriBell Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having CeriBell in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large Growth Funds Thematic Idea Now
Large Growth Funds
Funds or Etfs that invest in stocks of large-sized companies with above-average risk and growth rate. The Large Growth Funds theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Growth Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out CeriBell Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy CeriBell Stock please use our How to buy in CeriBell Stock guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CeriBell. Projected growth potential of CeriBell fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive CeriBell assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (3.67) | Revenue Per Share | Quarterly Revenue Growth 0.314 | Return On Assets | Return On Equity |
The market value of CeriBell is measured differently than its book value, which is the value of CeriBell that is recorded on the company's balance sheet. Investors also form their own opinion of CeriBell's value that differs from its market value or its book value, called intrinsic value, which is CeriBell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CeriBell's market value can be influenced by many factors that don't directly affect CeriBell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between CeriBell's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CeriBell should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, CeriBell's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.